drugs

Nationwide Recall for Compounded Drugs from North Carolina Pharmacy

A state inspection of a pharmacy in Fayetteville, North Carolina, has led to the recall of more than 600 drugs in a variety of dosages and formulations, officials announced in late March. The U.S. Food and Drug Administration (FDA) and the North Carolina Board of Pharmacy (NCBOP) have issued a warning to medical professionals and patients regarding all compounded drugs made or distributed by the Prescription Center pharmacy, which has been since shut down. Compounded Drug Recall
Continue Reading »

Lupron Can Result in Serious Injury or Death

Lupron is a hormonal regulator that has several dangerous, if not oft-publicized side effects of which every patient should be aware. The drug is prescribed to help slow early-onset puberty in teenagers, to men who exhibit signs of prostate cancer, and to help treat women with endometriosis, a rare condition in which the lining of the uterus grows outside the actual uterus. According to the U.S.
Continue Reading »

Dangers and Severe Risks of Lisinopril

Most drugs used to treat chronic issues dealing with digestion or heart issues carry some risk of side effects, but some are worse than others. Lisinopril is a angiotensin-converting enzyme (ACE) inhibitor, used to treat congestive heart failure, hypertension, and reduce the risk of heart attack. It has been commonly prescribed since the FDA first approved it for patient use in the early 1990s.
Continue Reading »

Testosterone Therapy Gel Manufacturer Faces Lawsuits

In recent years, testosterone therapies to help men with erectile dysfunction or low testosterone levels have become more common than ever. With the advances in such medication, however, come advances in risks that accompany such treatment. According to WebMD.com, testosterone replacement therapy (TRT), are not as common as one may think.
Continue Reading »

Lawsuits Brought Against Eli Lilly, Manufacturer of Cymbalta

Cymbalta is a multi-use prescription drug most commonly used as an anti-depressant. Despite several clinical trials during the approval process of Cymbalta that alleged Cymbalta caused depression in otherwise healthy patients, the U.S. Food and Drug Administration did not recall the drug for use as an anti-depressant, according to the New York Times.
Continue Reading »

A Recall Issued For Yaz Was Not Publicized

Sometimes prominent drugs are recalled and no one knows about it. This was the case with a 2010 Food and Drug Administration (FDA) recall of the birth control Yaz, a contraceptive approved by the FDA for use among women as young as 14 years old. Yaz and Beyaz—a similar FDA-approved medication made by the same manufacturer, Berlex, Inc.—hit the market when it was approved in 2006, according to Drugs.com.
Continue Reading »

Mental Disorder Drug Linked to Risk of Compulsive Behavior

Abilify is the name brand of the medication aripirazole. Aripirazole is the medicine used to treat mental disorders such as bipolar disorder, severe mental depression and schizophrenia. No evidence has been released that proves that the drug does not do what it is intended to do, but there are some unexpected side effects of taking this medication about which many patients have filed lawsuits.
Continue Reading »

Antidepressant Paxil Linked to Birth Defects

When the antidepressant drug Paxil hit the consumer market in the early 1990s, it was hailed by the medical world as a wonder drug, able to relieve even the most severe cases of mental depression. Like most other antidepressants, Paxil is a selective serotonin reuptake inhibitor (SSRI). There have been widely-publicized side effects about SSRIs for the patient who takes them. However, not as much has been published about the effects SSRIs can have on babies born to women who are taking them.
Continue Reading »

Generic Drugs and Defective Drug Claims

A generic drug is an essential option for Americans, as it is sold at a lower cost than a name brand product. In fact, the FDA notes that generic brands can be as much as 85 percent lower in price. However, these lower prices are a direct result of several factors. One of these factors is that generic drug manufacturers are not required to “repeat the costly clinical trials of new drugs.”
Continue Reading »

Avandia Restrictions Lifted, Negative Side Effects Persist

Pharmaceutical giant GlaxoSmithKline has come under fire in recent years for paying doctors to promote drugs, according to Mercola.com. The practice is, surprisingly, a legal one, and “widespread in the drug industry.” At the end of 2013, however, Glaxo announced that it would stop the practice, as well as stop “compensating its sales representatives based on the number of prescriptions that doctors write,” according to Mercola.
Continue Reading »

Pages

  • Newland & Newland LLP, Attorneys, Arlington Heights, IL
  • Lawyer.com